Disclosed herein is a pharmaceutical composition comprising a
serotonin-norepinephrine reuptake inhibitor and an alpha-2B receptor
agonist. The composition is effective for treating chronic pain, and
methods of treating pain using the composition and compounds comprising
it are also disclosed.